Clinical trial
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery…
NCT05755711 · Shockwave Medical, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT05755711 |
|---|---|
| Title | Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease |
| Official title | Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease |
| Acronym | EMPOWER CAD |
| Lead sponsor | Shockwave Medical, Inc., Industry |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Shockwave Medical Coronary IVL System |
| Enrollment | 399 |
| Start date | May 3, 2023 |
| Primary completion | Dec 11, 2024 |
| Completion | Apr 1, 2028 |
| First posted | Mar 6, 2023 |
| Last update posted | Jan 22, 2026 |
| Countries | France, Germany, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: